Literature DB >> 50763

Naturally occurring anti-inflammatory factors in the synovial fluids of patients with rheumatic disease and their possible mode of action.

R B Capstick, D A Lewis, J A Cosh.   

Abstract

Evidence has been shown that pathological synovial fluid contained a substance capable of stabilizing rat liver lysosomes which was partly inactivated by treatment with trypsin and by storage. Such synovial fluid also appeared to contain a substance which labilized lysosomes and which was more stable than the stabilizing substance. (2) The lysosomal stabilizing substance described above was nondialysable and migrated electrophoretically with the alpha and beta globulins to which class it has been tentatively ascribed. (3) Pathological synovial fluid contained proteases which were active at acid pH and at neutral pH. It also appeared to contain a substance capable of inhibiting these proteases. (4) Alpha2-Macroglobulin has been detected in pathogenic synovial fluid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50763      PMCID: PMC1006399          DOI: 10.1136/ard.34.3.213

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  ANTIPHLOGISTIC ACTION OF GRANULOMA POUCH EXUDATES IN INTACT OR ADRENALECTOMIZED RATS.

Authors:  G DIPASQUALE; R J GIRERD; V L BEACH; B G STEINETZ
Journal:  Am J Physiol       Date:  1963-12

2.  Acid phosphatase and catheptic activity in rheumatoid synovial tissue.

Authors:  M LUSCOMBE
Journal:  Nature       Date:  1963-03-09       Impact factor: 49.962

3.  Aetiological factors in the collagen diseases. Lysosomal enzymes and the degradation of cartilage matrix.

Authors:  J T DINGLE
Journal:  Proc R Soc Med       Date:  1962-02

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Lysosome stabilization by adjuvant arthritis serum.

Authors:  R H Persellin
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

6.  Separation of irritancy from the anti-inflammatory component of inflammation exudate.

Authors:  M E Billingham; B V Robinson
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

7.  New methods for the determination of elastase.

Authors:  H Rinderknecht; M C Geokas; P Silverman; Y Lillard; B J Haverback
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

8.  Changes in liver lysosome fragility, erythrocyte membrane stability, and local and systemic lysosomal enzyme levels in adjuvant-induced polyarthritis.

Authors:  L J Ignarro; J Slywka
Journal:  Biochem Pharmacol       Date:  1972-03-15       Impact factor: 5.858

9.  Lysosomal enzyme levels in the blood of arthritic rats.

Authors:  A J Collins; D A Lewis
Journal:  Biochem Pharmacol       Date:  1971-01       Impact factor: 5.858

10.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

View more
  4 in total

1.  Migration inhibition factor-like activity in inflammatory synovial fluids might be due to proteases.

Authors:  C Geiger; T L Vischer
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

2.  Putrescine--a potent endogenous anti-inflammatory substance in inflammatory exudates.

Authors:  J Bird; S Mohd-Hidir; D A Lewis
Journal:  Agents Actions       Date:  1983-06

3.  Inhibition of human neutrophil locomotion by the polyamine oxidase-polyamine system.

Authors:  A Ferrante
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

4.  Polyamine oxidase activity in rheumatoid arthritis synovial fluid.

Authors:  A Ferrante; R J Storer; L J Cleland
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.